| abstract |
A novel inhalable compound medicine is provided. An inhalable compound composition comprising an effective amount of sputum 2 -agonists and major components such as corticosteroids and, where necessary, a medically acceptable carrier. It can be used as an emergency administration of asthma attacks in asthma or chronic pulmonary obstruction patients, as a polarization control administration before going to bed or when waking up, and to reduce the occurrence of Β 2 -agonist drug acute drug resistance phenomenon. [Selection figure] None |